PortfoliosLab logoPortfoliosLab logo
ACMR vs. TRVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ACMR vs. TRVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ACM Research, Inc. (ACMR) and Trevi Therapeutics, Inc. (TRVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACMR achieves a 138.15% return, which is significantly higher than TRVI's 13.50% return.


ACMR

1D
2.45%
1M
45.10%
YTD
138.15%
6M
141.95%
1Y
265.21%
3Y*
104.60%
5Y*
25.99%
10Y*

TRVI

1D
5.57%
1M
-6.94%
YTD
13.50%
6M
11.28%
1Y
130.31%
3Y*
75.70%
5Y*
44.83%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ACMR vs. TRVI - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
ACMR
ACM Research, Inc.
138.15%161.26%-22.72%153.44%-72.87%4.95%340.38%0.71%
TRVI
Trevi Therapeutics, Inc.
13.50%203.88%207.46%-30.57%146.74%-67.68%-35.47%-60.53%

Correlation

The correlation between ACMR and TRVI is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since May 7, 2019

0.13

Fundamentals

EPS

ACMR:

$1.33

TRVI:

-$0.43

Total Revenue (TTM)

ACMR:

$960.23M

TRVI:

$0.00

Gross Profit (TTM)

ACMR:

$424.76M

TRVI:

-$31.00K

EBITDA (TTM)

ACMR:

$162.91M

TRVI:

-$49.16M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACMR vs. TRVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACMR
ACMR Risk / Return Rank: 9494
Overall Rank
ACMR Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
ACMR Sortino Ratio Rank: 9191
Sortino Ratio Rank
ACMR Omega Ratio Rank: 9292
Omega Ratio Rank
ACMR Calmar Ratio Rank: 9494
Calmar Ratio Rank
ACMR Martin Ratio Rank: 9393
Martin Ratio Rank

TRVI
TRVI Risk / Return Rank: 8989
Overall Rank
TRVI Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
TRVI Sortino Ratio Rank: 8787
Sortino Ratio Rank
TRVI Omega Ratio Rank: 8686
Omega Ratio Rank
TRVI Calmar Ratio Rank: 9191
Calmar Ratio Rank
TRVI Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACMR vs. TRVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ACM Research, Inc. (ACMR) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ACMRTRVIDifference
Sharpe ratioReturn per unit of total volatility

+1.27

Sortino ratioReturn per unit of downside risk

+0.46

Omega ratioGain probability vs. loss probability

1.45

1.35

+0.10

Calmar ratioReturn relative to maximum drawdown

5.76

4.44

+1.32

Martin ratioReturn relative to average drawdown

14.73

10.40

+4.33

ACMR vs. TRVI - Sharpe Ratio Comparison

The current ACMR Sharpe Ratio is 3.44, which is higher than the TRVI Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of ACMR and TRVI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ACMR vs. TRVI - Drawdown Comparison

The maximum ACMR drawdown since its inception was -87.23%, smaller than the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for ACMR and TRVI.


Loading charts...

Drawdown Indicators


ACMRTRVIDifference

Max Drawdown

Largest peak-to-trough decline

-87.23%

-95.45%

+8.22%

Max Drawdown (1Y)

Largest decline over 1 year

-46.34%

-29.50%

-16.84%

Max Drawdown (3Y)

Largest decline over 3 years

-58.42%

-61.96%

+3.54%

Max Drawdown (5Y)

Largest decline over 5 years

-84.81%

-80.26%

-4.55%

Current Drawdown

Current decline from peak

0.00%

-7.73%

+7.73%

Average Drawdown

Average peak-to-trough decline

-39.55%

-61.49%

+21.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.11%

12.58%

+5.53%

Volatility

ACMR vs. TRVI - Volatility Comparison

ACM Research, Inc. (ACMR) has a higher volatility of 33.26% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that ACMR's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACMRTRVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.26%

13.78%

+19.48%

Volatility (6M)

Calculated over the trailing 6-month period

59.35%

39.38%

+19.97%

Volatility (1Y)

Calculated over the trailing 1-year period

77.68%

60.39%

+17.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.77%

88.26%

-7.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.99%

99.35%

-15.36%

Dividends

ACMR vs. TRVI - Dividend Comparison

Neither ACMR nor TRVI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ACMR vs. TRVI - Financials Comparison

This section allows you to compare key financial metrics between ACM Research, Inc. and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20222023202420252026
231.26M
0
(ACMR) Total Revenue
(TRVI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ACMR and TRVI have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ACMR has higher volatility (33.26%) compared to TRVI (13.78%). In terms of maximum drawdown, ACMR dropped -87.23% vs TRVI's -95.45%.

ACMR currently has the higher Sharpe Ratio (3.44 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACMR and TRVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer